Associated Papers
NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
Shah PA et al.
Cells, 2020
33322834 (PubMed )
Supplement: cells-09-02677-s001.zip › cells-891042-supplementary.xlsx › Table_S2
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.
Su D et al.
Nature Communications, 2019
31700061 (PubMed )
Supplement: 41467_2019_12846_MOESM6_ESM.xlsx › Sheet1
PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.
Sambandam V et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2019
Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease.
Nisa L et al.
Molecular Cancer Research : Mcr, 2018
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
Cheng H et al.
Cell Reports, 2018
30380422 (PubMed )
Supplement: NIHMS1511993-supplement-7.xlsx › Table_S6A
Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing.
Wang Y et al.
Oncotarget, 2016
27564104 (PubMed )
Supplement: oncotarget-07-65208-s001.pdf
Select a paper to view details